2021 annual financial data
Solid Biosciences 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -570.95%.
Operating income was -72,254,000 USD and net income was -72,188,000 USD.
Operating cash flow was -77,764,000 USD.
Get free Solid Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,620,000 USD
- Operating income
- -72,254,000 USD
- Net income
- -72,188,000 USD
- Operating cash flow
- -77,764,000 USD